Blueprint Medicines(BPMC) - 2018 Q4 - Earnings Call Transcript

Blueprint Medicines (NASDAQ:BPMC) Q4 2018 Earnings Conference Call February 26, 2019 8:30 AM ET Company Participants Jim Baker - Vice President, Corporate Affairs Jeff Albers - Chief Executive Officer Kate Haviland - Chief Operating Officer Andy Boral - Chief Medical Officer Mike Landsittel - Chief Finance Officer Conference Call Participants Jason Jakoby - Goldman Sachs Marc Frahm - Cowen and Company Arlinda Lee - Canaccord Charles Zhu - Guggenheim Partners Operator Good day, ladies and gentlemen, and welc ...